Qingsong Capital
Asia, Beijing, China, Beijing'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Qingsong Capital is a an entrepreneurial private equity investment institution focusing on the field of biotechnology and medical health.
Investor Profile
Qingsong Capital has backed more than 9 startups, with 6 new investments in the last 12 months alone. The firm has led 2 rounds, about 22% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series C rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Medical, Health Care.
- Led 2 rounds in the past year.
Stage Focus
- Series A (44%)
- Series Unknown (22%)
- Series C (11%)
- Series B (11%)
- Seed (11%)
Country Focus
- China (89%)
Industry Focus
- Biotechnology
- Medical
- Health Care
- Pharmaceutical
- Medical Device
- Clinical Trials
- Precision Medicine
- Oncology
- Agriculture
- Livestock
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
